Molecular diagnostics
PCR-based molecular testing and technologies used in infectious-disease detection and other diagnostic applications.
STONE CLINICAL LABORATORIES
Science in focus.
Progress in motion.
Explore the work, milestones and published news behind Stone Clinical Laboratories, a New Orleans-founded clinical diagnostics company whose story continues to evolve.
Source-linked company history Curated published coverage
LABORATORY SCIENCE ＋
FOCUS AREAClinical diagnostics
ORIGINSNew Orleans
Clinical laboratory roots in Louisiana
DISCIPLINEMolecular science
PCR and broader clinical testing
EVOLUTIONSTONE Diagnostics
A name shared in a 2022 company update
2025 MILESTONEFibronostics
Acquisition announced in October 2025
THE COMPANY
A history of making diagnostic information more accessible.
Stone Clinical Laboratories developed a portfolio spanning molecular testing, general laboratory services and patient-focused support. Its published materials describe a flexible approach to laboratory operations and clinical partnerships.
Get to know StoneClinical laboratory services
Services described by the company include chemistry, hematology, microbiology, toxicology and pharmacogenetics.
Flexible service models
Published company materials describe regional laboratories, mobile testing modules and provider-support capabilities.
SELECTED COVERAGE
Stories worth exploring.
Business & GrowthOCT 27, 2025
Fibronostics announces acquisition of Stone Clinical Laboratories
The 2025 announcement outlines the integration of Stone’s laboratory capabilities with Fibronostics’ work in non-invasive liver and metabolic diagnostics.
Fibronostics / PR NewswireRead source
Company Milestones2022
Stone Clinical Laboratories introduces the STONE Diagnostics name
The company shared its branding transition and new headquarters in Santa Rosa Beach, Florida, in a public update.
STONE Diagnostics / LinkedInRead source
PartnershipsMAY 24, 2021
Stone Capital Group announces collaboration with LumiraDx
The services and co-marketing partnership focused on making point-of-care and laboratory COVID-19 testing available to mass-screening settings.
STONE DiagnosticsRead source
COMPANY MOMENTS
The story, at a glance.
Publicly documented milestones that reflect the company's development over time.
See the full archive2019CAP accreditation announced and payer relationships expanded.
2020–21Public-health testing and technology partnerships were announced.
2022The company publicly introduced the STONE Diagnostics name.
2025Fibronostics announced its acquisition of Stone Clinical Laboratories.
EXPLORE FURTHER
Follow the story back to the source.
Visit the STONE Diagnostics website for company information, or browse our curated collection of published updates.